These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4250587)

  • 1. [Staphylococcal hepatitis treated with the aid of bacteriophages].
    Samet A; Kucharski A; Kopacz A
    Pol Przegl Chir; 1970 Dec; 42(12):1754-6. PubMed ID: 4250587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anatoxin and bacteriophage treatment of staphylococcal complications in patients with infectious hepatitis].
    Proskurov VA
    Vrach Delo; 1969 Nov; 11():118-20. PubMed ID: 4247252
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of new bacteriophages for phage-typing of Staphylococcus aureus.
    Pillich J; Kocourková D; Krivánková M; Pulverer G
    Pathol Microbiol (Basel); 1971; 37(5):347-51. PubMed ID: 4256860
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assumptions for successful therapy using staphylococcal phage lysates].
    Pillich J; Výmola F; Buda J
    Zentralbl Bakteriol Orig; 1969 Jul; 210(3):377-81. PubMed ID: 4243228
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections.
    Slopek S; Kucharewicz-Krukowska A; Weber-Dabrowska B; Dabrowski M
    Arch Immunol Ther Exp (Warsz); 1985; 33(2):261-73. PubMed ID: 2935117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of staphylococcal bacteriophage in the treatment of patients with odontogenic suppurative-inflammatory diseases of perimaxillary tissues].
    Biberman IaM; Kats AG; Mordvinova NB
    Stomatologiia (Mosk); 1977; 56(1):60-3. PubMed ID: 138977
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed infection with methicilin-resistant and methicillin-sensitive Staphylococcus aureus of phage type 88.
    Annear DI
    Med J Aust; 1971 May; 1(22):1167-8. PubMed ID: 4254076
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phage-typing and lysogenicity of Staphylococci isolated from chronic infections].
    Krivánková M; Pillich J; Pulverer G; Spieckermann C
    Zentralbl Bakteriol Orig A; 1971 Nov; 218(3):286-9. PubMed ID: 4400264
    [No Abstract]   [Full Text] [Related]  

  • 9. Differentiation of coagulase-negative staphylococci by bacteriophage-typing.
    Pulverer G; Pillich J; KRIVANKOVA M
    Contrib Microbiol Immunol; 1973; 1():503-8. PubMed ID: 4281737
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carriers of Staphylococcus aureus in a surgery department. Phage typing and study of sensitivity to antibiotics].
    Herrera VR; Henríquez M; Vidal N
    Rev Med Chil; 1984 Mar; 112(3):242-6. PubMed ID: 6236535
    [No Abstract]   [Full Text] [Related]  

  • 11. Staphylococcal mastitis: phage types and patterns of S. aureus.
    Giesecke WH; van den Heever LW; du Toit IJ
    Onderstepoort J Vet Res; 1972 Jun; 39(2):87-96. PubMed ID: 4268643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of patients with staphylococcal infections of laryngologic organs with anatoxin and bacteriophage].
    Proskurov VA
    Zh Ushn Nos Gorl Bolezn; 1969; 29(3):101. PubMed ID: 4243326
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacterial interference: its effect on nursery-acquired infection with Staphylococcus aureus. VI. Detection of implanted Staphylococcus aureus strain. Use of serological and phage typing.
    COHEN JO; SMITH PB; SHOTTS EB; BORIS M; UPDYKE EL
    Am J Dis Child; 1963 Jun; 105():689-91. PubMed ID: 14022058
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of furazolidon and bacteriophage in staphylococcal diseases].
    Proskurov VA
    Vrach Delo; 1972 Mar; 3():144-7. PubMed ID: 4261640
    [No Abstract]   [Full Text] [Related]  

  • 15. [LYSOTYPE STUDIES IN STAPHYLOGENIC DISEASES].
    CHIARI HH; DUFEK H; NEUHOLD R
    Wien Z Inn Med; 1963 Jul; 44():327-32. PubMed ID: 14054754
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation of bacteriophage from lysogenic staphylococci for epidemiologic studies.
    CHANG SS; LIU JL
    Taiwan Yi Xue Hui Za Zhi; 1962 May; 61():436-44. PubMed ID: 14020071
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacteriophage therapy against staphylococci.
    Klem J; Dömötör D; Schneider G; Kovács T; Tóth A; Rákhely G
    Acta Microbiol Immunol Hung; 2013 Dec; 60(4):411-22. PubMed ID: 24292085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phage group affinity of staphylococci isolated from inflammatory-purulent lesions and the formation of enterotoxin].
    Paster EU; Martyniuk BN
    Mikrobiol Zh; 1974; 36(3):319-22. PubMed ID: 4282751
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the interrelation of the resistance of pathogenic staphylococci to antibiotics, their virulence and phage type].
    CHISTOVICH GN
    Antibiotiki; 1963 Jan; 8():64-7. PubMed ID: 14020901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phage-typing in the surveillance of hospital infections: tests on strains of Staphylococcus aureus].
    Moiraghi Ruggenini A; Vanini GC; Maury F; Grassi R; Garella D
    G Batteriol Virol Immunol; 1983; 76(7-12):218-26. PubMed ID: 6241575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.